Adicet Bio Stock Based Compensation Over Time

ACET Stock  USD 0.91  0.05  5.81%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Adicet Bio Performance and Adicet Bio Correlation.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
  
Stock Based Compensation is likely to gain to about 21.3 M in 2024, whereas Stock Based Compensation To Revenue is likely to drop 0.50 in 2024.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.70)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.29)
Return On Equity
(0.58)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Stock Based Compensation Analysis

Compare Adicet Bio and related stocks such as Edgewise Therapeutics, Talaris Therapeutics, and Cullinan Oncology LLC Stock Based Compensation Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
EWTX77 K77 K77 K77 K77 K77 K77 K77 K77 K77 K354 K4.4 M10.9 M17.6 M18.4 M
CGEM17 K17 K17 K17 K17 K17 K17 K17 K17 K17 K14.9 M24.4 M28 M30.4 M21.5 M
VOR116 K116 K116 K116 K116 K116 K116 K116 K116 K172 K1.3 M4.3 M10.7 M13.4 M14 M
TNYA414 K414 K414 K414 K414 K414 K414 K414 K414 K414 K741 KM11.5 M15.3 M16.1 M
BCYC515 K515 K515 K515 K515 K515 K515 K515 KM3.1 M6.5 M12.1 M26.8 M32.5 M34.1 M
IGMS93 K93 K93 K93 K93 K93 K93 K93 K183 KM8.5 M25.9 M44.7 M46.5 M48.9 M
GLUE0.00.00.00.00.00.00.00.00.00.0354 K5.2 M11.7 M16.7 M17.5 M
STOK26 K26 K26 K26 K26 K26 K26 K26 K240 K1.9 M5.8 M16.4 M22.9 M25.3 M26.5 M
AVTE0.00.00.00.00.00.00.00.00.00.058 KM5.5 M11.9 M12.5 M
ACRVKKKKKKKKKKK497 K2.2 M11.6 M12.2 M
ANEB199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K199.9 K480.7 K884.7 K758.9 K639.2 K
AGIO371 K371 K742 KM11.5 M32 M42.1 M47.8 M73.4 M72.4 M61.6 M53.5 M49.3 M44.8 M41.7 M
NKTX182.5 K182.5 K182.5 K182.5 K182.5 K182.5 K182.5 K182.5 K182.5 K947 K6.7 M14.5 M16.9 M17.2 M10.3 M
PLRX228 K228 K228 K228 K228 K228 K228 K228 K228 K1.8 M3.9 M10.4 M22.6 M44.5 M46.7 M
ALECMMMMMMM5.4 M6.9 M16.3 M30.5 M40.8 M46.1 M42.8 M26.2 M
AADI649.4 K649.4 K649.4 K649.4 K649.4 K649.4 K649.4 K649.4 K3.4 M106.1 K139 K2.1 M9.6 M12 M12.6 M
KROS81 K81 K81 K81 K81 K81 K81 K81 K81 K59 K4.1 M11.7 M18.7 M28.8 M30.2 M

Adicet Bio and related stocks such as Edgewise Therapeutics, Talaris Therapeutics, and Cullinan Oncology LLC Stock Based Compensation description

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

My Equities

My Current Equities and Potential Positions

Adicet Bio
ACET
Specialization
Health Care, Health Care Equipment & Services
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 0.91

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.